AU2012261508A1 - Wise binding antibodies and epitopes - Google Patents

Wise binding antibodies and epitopes

Info

Publication number
AU2012261508A1
AU2012261508A1 AU2012261508A AU2012261508A AU2012261508A1 AU 2012261508 A1 AU2012261508 A1 AU 2012261508A1 AU 2012261508 A AU2012261508 A AU 2012261508A AU 2012261508 A AU2012261508 A AU 2012261508A AU 2012261508 A1 AU2012261508 A1 AU 2012261508A1
Authority
AU
Australia
Prior art keywords
epitopes
binding antibodies
wise binding
wise
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012261508A
Inventor
Kevin Graham
Xueming Qian
Grant Shimamoto
Barbara S. Tipton
Mei-Mei Tsai
Aaron George Winters
Li Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to AU2012261508A priority Critical patent/AU2012261508A1/en
Publication of AU2012261508A1 publication Critical patent/AU2012261508A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to binding agents for WISE such as antibodies, and includes for their manufacture and use.
AU2012261508A 2007-11-21 2012-11-30 Wise binding antibodies and epitopes Abandoned AU2012261508A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012261508A AU2012261508A1 (en) 2007-11-21 2012-11-30 Wise binding antibodies and epitopes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/004,037 2007-11-21
AU2008330125 2008-11-21
AU2012261508A AU2012261508A1 (en) 2007-11-21 2012-11-30 Wise binding antibodies and epitopes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2008330125A Division AU2008330125B2 (en) 2007-11-21 2008-11-21 Wise binding antibodies and epitopes

Publications (1)

Publication Number Publication Date
AU2012261508A1 true AU2012261508A1 (en) 2012-12-20

Family

ID=47360296

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012261508A Abandoned AU2012261508A1 (en) 2007-11-21 2012-11-30 Wise binding antibodies and epitopes

Country Status (1)

Country Link
AU (1) AU2012261508A1 (en)

Similar Documents

Publication Publication Date Title
TN2010000213A1 (en) Wise binding antibodies and epitopes
WO2011075636A3 (en) Wise binding agents and epitopes
MX2010006396A (en) Bivalent, bispecific antibodies.
UA100874C2 (en) Bivalent bispecific antibodies
MX2010005682A (en) Bivalent, bispecific antibodies.
MX2010005888A (en) Bivalent, bispecific antibodies.
WO2009052400A8 (en) Antibodies that bind to mammalian ngal and uses thereof
MX345909B (en) Anti-fgfr3 antibodies and methods using same.
MY171841A (en) Antibody formulation
MX2020005214A (en) Antibody formulations.
WO2008150485A3 (en) Erbb2 binding proteins and use thereof
WO2009128963A3 (en) Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
MX2009004167A (en) Antibodies that bind cxcr7 epitopes.
SG162728A1 (en) Tweak binding antibodies
WO2008021156A3 (en) Antibodies to il-17a
MA32190B1 (en) Antibodies to angiopoietin 1 and angiopoietin 2 and their use
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200626171A (en) Fixed dosing of HER antibodies
WO2008060705A8 (en) Anti-dll4 antibodies and methods using same
MY162791A (en) Anti-il-23 antibodies
WO2007130697A3 (en) Anti-ephb4 antibodies and methods using same
WO2009039307A3 (en) Hydrogels and methods for producing and using the same
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
MX2011010012A (en) Novel anti-î+-5î²1 antibodies and uses thereof.
WO2009055074A8 (en) Erbb2 binding proteins and use thereof

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application